Jubilant Pharmova Ltd

About [ edit ]

Jubilant Life Sciences is an integrated global pharmaceutical and life sciences company engaged in pharmaceuticals, life science ingredients and drug discovery and development solutions. The pharmaceuticals segment, through its wholly owned subsidiary Jubilant Pharma Limited, is engaged in manufacture and supply of APIs, solid dosage formulations, radiopharmaceuticals, allergy therapy products and contract manufacturing of sterile injectables and non-sterile products through 6 USFDA approved manufacturing facilities in India, USA and Canada and a network of over 50 radiopharmacies in the US.

  • Market Cap 13,261 Cr.
  • Current Price 832
  • High / Low 999 / 380
  • Stock P/E 15.0
  • Book Value 375
  • Dividend Yield 0.60 %
  • ROCE 15.3 %
  • ROE 17.8 %
  • Face Value 1.00

Pros

Cons

  • Company might be capitalizing the interest cost
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2018 Jun 2018 Sep 2018 Dec 2018 Mar 2019 Jun 2019 Sep 2019 Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020
2,252 2,079 2,269 2,377 2,386 2,182 2,266 1,518 2,391 1,893 1,591 1,771
1,794 1,641 1,819 1,884 2,028 1,747 1,797 1,108 1,855 1,591 1,242 1,282
Operating Profit 458 438 450 493 358 435 468 410 537 302 350 490
OPM % 20% 21% 20% 21% 15% 20% 21% 27% 22% 16% 22% 28%
Other Income 23 -12 -5 14 -241 10 12 16 19 8 81 84
Interest 72 51 54 53 62 73 72 49 71 76 46 46
Depreciation 182 88 89 98 95 103 117 84 129 112 85 96
Profit before tax 227 286 302 356 -40 269 292 294 356 122 299 431
Tax % 33% 30% 30% 25% -152% 31% 15% 31% 27% 28% 25% 28%
Net Profit 155 202 210 261 -99 185 249 203 260 88 224 310
EPS in Rs 9.72 12.71 13.21 16.37 -6.23 11.61 15.66 12.77 16.35 5.52 14.06 19.46

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 TTM
3,485 3,749 3,420 4,270 5,132 5,762 5,751 5,749 5,861 7,518 9,111 9,154 7,647
2,795 3,064 2,854 3,379 4,134 4,763 5,141 4,493 4,510 5,995 7,367 7,205 5,969
Operating Profit 690 684 565 891 999 999 610 1,256 1,352 1,522 1,744 1,950 1,678
OPM % 20% 18% 17% 21% 19% 17% 11% 22% 23% 20% 19% 21% 22%
Other Income 96 27 -25 -318 -93 -173 86 4 19 36 -249 10 192
Interest 326 69 120 238 311 337 368 371 341 284 220 287 240
Depreciation 163 125 180 221 254 281 288 347 291 415 371 462 422
Profit before tax 297 518 241 114 341 207 40 542 738 859 904 1,211 1,208
Tax % 9% 19% 6% 60% 45% 34% 200% 29% 22% 26% 36% 26%
Net Profit 283 421 230 15 153 109 -58 392 576 643 574 898 882
EPS in Rs 19.20 26.56 14.42 0.91 9.59 6.84 -3.63 24.60 36.14 40.35 36.06 56.39 55.39
Dividend Payout % 8% 8% 14% 328% 31% 43% -83% 12% 8% 7% 12% 9%
Compounded Sales Growth
10 Years:9%
5 Years:10%
3 Years:16%
TTM:-8%
Compounded Profit Growth
10 Years:8%
5 Years:78%
3 Years:17%
TTM:21%
Stock Price CAGR
10 Years:19%
5 Years:20%
3 Years:4%
1 Year:108%
Return on Equity
10 Years:13%
5 Years:17%
3 Years:17%
Last Year:18%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Sep 2020
15 16 16 16 16 15 16 16 16 16 16 16 16
Reserves 1,528 2,185 2,156 2,241 2,460 2,611 2,438 2,951 3,420 4,071 4,793 5,588 5,963
Borrowings 3,942 3,173 3,926 3,818 4,245 4,395 4,793 4,493 4,045 3,469 4,840 4,808 3,999
1,278 1,450 1,434 1,688 1,650 1,842 1,372 1,280 1,417 1,902 1,670 1,898 2,408
Total Liabilities 6,762 6,825 7,532 7,763 8,371 8,864 8,619 8,740 8,899 9,457 11,319 12,310 12,386
3,745 3,819 3,991 4,460 4,967 5,099 4,911 5,104 5,107 5,401 5,648 6,340 6,864
CWIP 503 506 667 686 437 472 597 611 684 671 901 768 259
Investments 271 256 33 19 26 34 40 85 103 124 115 69 78
2,243 2,244 2,841 2,598 2,941 3,259 3,071 2,939 3,006 3,262 4,654 5,133 5,186
Total Assets 6,762 6,825 7,532 7,763 8,371 8,864 8,619 8,740 8,899 9,457 11,319 12,310 12,386

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
457 701 390 707 970 772 783 1,099 1,268 1,303 1,122 1,543
-1,857 -279 -455 -596 -504 -164 -362 -309 -465 -614 -1,018 -267
1,252 -298 608 -889 -450 -414 -503 -843 -686 -901 657 -1,050
Net Cash Flow -148 124 543 -778 17 194 -82 -52 117 -212 761 225

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
ROCE % 14% 11% 7% 12% 12% 11% 6% 13% 15% 15% 16% 15%
Debtor Days 53 50 56 56 50 51 52 60 63 55 51 52
Inventory Turnover 3.00 2.63 2.26 2.22 2.26 2.30 2.37 2.04 1.93 2.52 2.84 2.22

Shareholding Pattern

Numbers in percentages

Jun 2018 Sep 2018 Dec 2018 Mar 2019 Jun 2019 Sep 2019 Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021
50.68 50.68 50.68 50.68 50.68 50.68 50.68 50.68 50.68 50.68 50.68 50.68
23.95 24.41 24.89 26.74 27.02 27.20 27.43 27.91 26.96 26.05 25.73 25.69
5.35 4.60 4.48 4.78 4.64 2.61 2.66 1.87 1.57 1.13 1.02 1.28
17.82 18.12 17.76 17.80 17.67 19.52 19.24 19.54 20.79 22.15 22.57 22.29
2.20 2.20 2.19 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.07

Documents